https://www.inibio.eu/news/iocb-tech-group-successfully-represents-the-czech-republic-at-the-prestigious-biotech-conference-bio-europe-2023 2026-02-16 https://www.inibio.eu/news/heartbeat.bio-raises-%E2%82%AC4.5m-in-pre-series-a-financing-to-drive-development-of-organoid-screening-platform-for-cardiac-drug-discovery 2026-02-16 https://www.inibio.eu/news/%C4%8Desk%C3%A1-spo%C5%99itelna-is-the-first-bank-in-the-czech-republic-to-invest-eur-5-million-in-an-academic-investment-fund-i%26i-bio-focused-on-drug-development-and-medical-innovations 2026-02-16 https://www.inibio.eu/news/delta-life-science-raises-%E2%82%AC5.25m-from-i%26i-bio-and-other-investors-in-series-a-funding-to-revolutionize-biosensing-technology 2026-02-16 https://www.inibio.eu/news/i%26i-biotech-fund-will-invest-up-to-eur-340-000-into-czech-startup-sophomer-s.r.o.-the-funding-will-support-further-technology-development 2026-02-16 https://www.inibio.eu/news/the-advisory-committee-of-i%26i-biotech-fund-strengthened-by-renowned-economist-daniel-m%C3%BCnich 2026-02-16 https://www.inibio.eu/news/experienced-businessmen-join-forces-with-excellent-science%2C-invest-%E2%82%AC2m-in-the-fund-at-the-iocb 2026-02-16 https://www.inibio.eu/news/i%26i-biotech-fund-invests-more-than-%E2%82%AC1m-in-enzyre-to-help-advancing-pioneering-diagnostic-technology-platform-for-hemophilia-patients 2026-02-16 https://www.inibio.eu/news/celeris-therapeutics-to-receive-12.5m-euros-in-funding-from-the-european-innovation-council 2026-02-16 https://www.inibio.eu/news/nanoligent-raised-%E2%82%AC2.8-m-and-completed-seed-round-financing-with-support-of-i%26i-bio 2026-02-16 https://www.inibio.eu/news/casinvent-pharma-raises-%E2%82%AC1.3-million-from-khan-i-and-i%26i-biotech-fund-to-support-the-development-of-new-casein-kinase-1-inhibitors-for-the-treatment-of-leukemias-and-solid-tumors 2026-02-16 https://www.inibio.eu/news/notes-from-a-trip-to-%E2%80%9Cthe-most-startup-friendly-country-in-the-world%E2%80%9D 2026-02-16 https://www.inibio.eu/news/i%26i-bio-invests-%241.5-million-in-sampling-human-to-support-the-development-of-engineered-cells-for-single-cell-analysis 2026-02-16 https://www.inibio.eu/news/i%26i-biotech-fund-invests-eur-1-million-in-celeris-therapeutics-company-using-ai-to-develop-drugs- 2026-02-16 https://www.inibio.eu/news/new-academic-fund-to-support-research-startups-with-more-than-45-million-euros 2026-02-16 https://www.inibio.eu/news/t-curx-announces-%2420m-series-a-first-closing-led-by-biomedvc-to-fund-pipeline-of-clinical-stage-car-t-programs-and-advance-proprietary-non-viral-in-vivo-car-t-platform 2025-12-20 https://www.inibio.eu/news/captain-t-cell-closes-financing-round-to-advance-its-proprietary%2C-next-generation-tcr-t-pipeline-into-the-clinic- 2026-02-16 https://www.inibio.eu/news/heartbeat.bio-joins-forces-with-boehringer-ingelheim-to-advance-gene-therapies-for-inherited-heart-muscle-disorders 2026-02-16 https://www.inibio.eu/news/kydo-therapeutics-announces-%E2%82%AC4.45-million-seed-financing-to-advance-its-covalent-allosteric-inhibitor-platform-to-address-highly-unmet-medical-needs-in-oncology 2026-02-16 https://www.inibio.eu/news/life-sciences-and-artificial-intelligence%3F-only-ten-per-cent-of-ai-is-used-in-a-truly-innovative-way%2C-the-rest-are-common-applications 2025-09-30 https://www.inibio.eu/news/by-leveraging-our-financial-support-and-expertise%2C-we-can-contribute-to-the-growth-and-success-of-startups-in-poland-and-the-baltic-countries 2025-09-30 https://www.inibio.eu/news/casinvent-pharma-raises-from-i%26i-biotech-fund-and-other-investors-%E2%82%AC1.6-million-to-support-the-development-of-ck1-inhibitors 2025-09-30 https://www.inibio.eu/news/captain-t-cell-secures-seed-financing-round-totaling-%E2%82%AC8.5m 2026-02-16 https://www.inibio.eu/news/uk%E2%80%99s-mhra-authorizes-vasa-to-initiate-first-in-human-clinical-trial-of-vs-041 2026-02-16 https://www.inibio.eu/news/iqure-seed 2026-02-16 https://www.inibio.eu/news/antiverse-seed-extension 2026-02-16